Evidence map›Paper›PMID 23075320›Full record

ArticleMolecular pharmaceutics2012

Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.

Geoffrey Y Berguig, Anthony J Convertine, Julie Shi, Maria Corinna Palanca-Wessels, Craig L Duvall, Suzie H Pun, Oliver W Press, Patrick S Stayton

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Design of smart HPMA copolymer-based nanomedicines.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
  10. Article
  11. Article
  12. Intracellular delivery system for antibody-Peptide drug conjugates.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Geoffrey Y BerguigDepartment of Bioengineering, University of Washington , Seattle, Washington 98195-5061, United States.
Anthony J Convertine
Julie Shi
Maria Corinna Palanca-Wessels
Craig L Duvall
Suzie H Pun
Oliver W Press
Patrick S Stayton
University of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
CAREER DEVELOPMENT IN PEDIATRIC AND MEDICAL ONCOLOGYK12CA076930 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DAVIDSON, NANCY ELLEN, MESHINCHI, SOHEIL · 1997 to 2025
$13.1M
Biofunctional Polymers for Intracellular Drug DeliveryR01EB002991 · NIBIB · UNIVERSITY OF WASHINGTON · PI STAYTON, PATRICK S. · 2003 to 2011
$3.9M
Intracellular delivery of proapoptotic peptide drugs for the treatment of cancerR21EB014572 · NIBIB · UNIVERSITY OF WASHINGTON · PI STAYTON, PATRICK S. · 2012 to 2013
$450k
Antibody directed delivery of short interfering RNA for the treatment of ovarianK08CA163603 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PALANCA-WESSELS, MARIA CORINNA · 2012 to 2013
$341k
NCI NIH HHS 2K12CA076930-11NCI NIH HHS K08 CA163603NCI NIH HHS K12 CA076930NCI NIH HHS P30 CA015704NIBIB NIH HHS R01 EB002991NIBIB NIH HHS R01EB002991NIBIB NIH HHS R21 EB014572
6 · The paper itself

Abstract

Ratiometric fluorescence and cellular fractionation studies were employed to characterize the intracellular trafficking dynamics of antibody-poly(propylacrylic acid) (PPAA) conjugates in CD22+ RAMOS-AW cells. The HD39 monoclonal antibody (mAb) directs CD22-dependent, receptor-mediated uptake in human B-cell lymphoma cells, where it is rapidly trafficked to the lysosomal compartment. To characterize the intracellular-release dynamics of the polymer-mAb conjugates, HD39-streptavidin (HD39/SA) was dual-labeled with pH-insensitive Alexa Fluor 488 and pH-sensitive pHrodo fluorophores. The subcellular pH distribution of the HD39/SA-polymer conjugates was quantified as a function of time by live-cell fluorescence microscopy, and the average intracellular pH value experienced by the conjugates was also characterized as a function of time by flow cytometry. PPAA was shown to alter the intracellular trafficking kinetics strongly relative to HD39/SA alone or HD39/SA conjugates with a control polymer, poly(methacryclic acid) (PMAA). Subcellular trafficking studies revealed that after 6 h, only 11% of the HD39/SA-PPAA conjugates had been trafficked to acidic lysosomal compartments with values at or below pH 5.6. In contrast, the average intracellular pH of HD39/SA alone dropped from 6.7 ± 0.2 at 1 h to 5.6 ± 0.5 after 3 h and 4.7 ± 0.6 after 6 h. Conjugation of the control polymer PMAA to HD39/SA showed an average pH drop similar to that of HD39/SA. Subcellular fractionation studies with tritium-labeled HD39/SA demonstrated that after 6 h, 89% of HD39/SA was associated with endosomes (Rab5+) and lysosomes (Lamp2+), while 45% of HD39/SA-PPAA was translocated to the cytosol (lactate dehydrogenase+). These results demonstrate the endosomal-releasing properties of PPAA with antibody-polymer conjugates and detail their intracellular trafficking dynamics and subcellular compartmental distributions over time.

Indexed as

Drug Delivery SystemsAntibodies, MonoclonalBurkitt LymphomaFlow CytometryHumansMicroscopy, FluorescencePolymersProtein TransportSialic Acid Binding Ig-like Lectin 2Subcellular FractionsTumor Cells, CulturedAntibodies, MonoclonalCD22 protein, humanPolymersSialic Acid Binding Ig-like Lectin 2

Identifiers

PMID23075320
PMCPMC3600396
OpenAlexW2032575458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.